Harrow Health, Inc.
Status: Publicly traded
Direct answer
Harrow Health, Inc. is publicly traded on NASDAQ under the ticker HROW.
Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical...
Can you invest in Harrow Health, Inc.?
Yes. Harrow Health, Inc. trades publicly on NASDAQ as HROW.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Harrow Health, Inc.
Detailed equity research is provided by MarketSnap.